Objection to DEA-1665 (Emergency scheduling of SR-17018) Submitted by Dr. Michele Ross

Written by Michele Ross, PhD
Michele Ross, PhD

Dr. Michele Ross is Principal Scientist at Infused Partners and a neuropharmacologist working at the intersection of opioid receptor pharmacology, chronic pain, and federal drug policy. She is also the author of Kratom is Medicine, Vitamin Weed, CBD Oil For Health, and Train Your Brain To Get Thin.

https://drmicheleross.com
Previous

Objection to DEA-1644 (Emergency scheduling of Kratom Alkaloid Mitragynine PSeudoindoxyl) Submitted by Dr. Michele Ross
Next

Eight Reasons Tianeptine Shouldn't Be Placed in Schedule I